Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEvraz Regulatory News (EVR)

  • This share is currently suspended. It was suspended at a price of 82.52

Share Price Information for Evraz (EVR)

Share Price is delayed by 15 minutes
Get Live Data
82.52    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: £1.20b
EVR Live PriceLast checked at - London Stock Exchange

Intraday Evraz Share Chart

Changes to the Board Committees

16 Jun 2015 15:13

RNS Number : 3305Q
Evraz Plc
16 June 2015
 



For immediate release

 

Changes to the Board Committees

 

16 June 2015 - EVRAZ Plc. (LSE: EVR) announces that the following changes will be made to the composition of the Board's Committees, with an effective date 19 June 2015:

 

• Ms Deborah Gudgeon, having joined the Audit Committee on 1 May 2015, will become Chairman of the Audit Committee (succeeding Terry Robinson);

• Mr Alexander Izosimov will join the Audit Committee;

• Mr Karl Gruber will join the Nominations Committee; and

• Sir Michael Peat will step down from the Audit Committee.

 

The Board Committees composition, effective from 19th June 2015, will be as follows:

 

Audit Committee

Ms Deborah Gudgeon - Chairman of the Committee

Mr Duncan Baxter

Mr Alexander Izosimov

Ms Olga Pokrovskaya

 

Remuneration Committee

Mr Duncan Baxter - Chairman of the Committee

Mr Karl Gruber

Mr Alexander Izosimov

 

Nominations Committee

Sir Michael Peat - Chairman of the Committee

Mr Alexander Abramov

Mr Eugene Shvidler

Mr Alexander Izosimov

Mr Karl Gruber

 

HSE Committee

Mr Karl Gruber - Chairman of the Committee

Ms Olga Pokrovskaya

Mr Alexander Frolov

 

 

 

For further information:

 

Media Relations:

London: +44 207 832 8998 Moscow: +7 495 937 6871

media@evraz.com

 

Investor Relations:

London: +44 207 832 8990 Moscow: +7 495 232 1370

ir@evraz.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFFMITMBMBBLA
Date   Source Headline
28th Feb 20237:00 amEQSDISCONTINUATION OF DISCLOSURE VIA PRIMARY INFORMATION PROVIDER
27th Feb 20237:00 amEQSCLARIFICATION ON ANNUAL REPORT AND AUDITED FINANCIAL STATEMENTS FOR 2022
28th Dec 20228:30 amEQSEVRAZ plc announces that the Appointment and the Amendments adopted as part of the Consent Solicitation for its outstanding U.S.$700,000,000 5.250 per cent. notes due 2024 have become effective
28th Dec 20227:30 amEQSEVRAZ plc announces that the Appointment and the Amendments adopted as part of the Consent Solicitation for its outstanding U.S.$700,000,000 5.250 per cent. notes due 2024 have become effective
23rd Dec 20228:30 amEQSEVRAZ plc announces results of the Consent Solicitation for its outstanding U.S.$700,000,000 5.250 per cent. notes due 2024
23rd Dec 20227:30 amEQSEVRAZ plc announces results of the Consent Solicitation for its outstanding U.S.$700,000,000 5.250 per cent. notes due 2024
19th Dec 202212:00 pmEQSEVRAZ plc announces that the Appointment and the Amendments adopted as part of the Consent Solicitation for its outstanding notes due 2023 have become effective
19th Dec 202211:00 amEQSEVRAZ plc announces that the Appointment and the Amendments adopted as part of the Consent Solicitation for its outstanding notes due 2023 have become effective
8th Dec 20229:17 amEQSEVRAZ plc announces results of the Consent Solicitation for its outstanding U.S.$750,000,000 5.375 per cent. notes due 2023
8th Dec 20229:15 amEQSNOTICE OF ADJOURNED MEETING to the holders of outstanding U.S.$700,000,000 5.250 per cent. notes due 2024 issued by the Issuer
8th Dec 20228:17 amEQSEVRAZ plc announces results of the Consent Solicitation for its outstanding U.S.$750,000,000 5.375 per cent. notes due 2023
8th Dec 20228:16 amEQSNOTICE OF ADJOURNED MEETING to the holders of outstanding U.S.$700,000,000 5.250 per cent. notes due 2024 issued by the Issuer
15th Nov 20228:10 amEQSEVRAZ plc announces Consent Solicitation in respect of its outstanding U.S.$750,000,000 5.375 per cent. notes due 2023
15th Nov 20228:10 amEQSEVRAZ plc announces Consent Solicitation in respect of its outstanding U.S.$700,000,000 5.250 per cent. notes due 2024
15th Nov 20227:10 amEQSEVRAZ plc announces Consent Solicitation in respect of its outstanding U.S.$750,000,000 5.375 per cent. notes due 2023
15th Nov 20227:10 amEQSEVRAZ plc announces Consent Solicitation in respect of its outstanding U.S.$700,000,000 5.250 per cent. notes due 2024
9th Nov 20221:45 pmEQSEVRAZ plc: ERNST & YOUNG TERMINATED ITS SERVICES FOR EVRAZ PLC
9th Nov 202212:46 pmEQSEVRAZ plc: ERNST & YOUNG TERMINATED ITS SERVICES FOR EVRAZ PLC
2nd Nov 20222:56 pmEQSEVRAZ plc: SANCTIONS IMPOSED ON MR. ABRAMOV AND MR. FROLOV
2nd Nov 20221:56 pmEQSEVRAZ plc: SANCTIONS IMPOSED ON MR. ABRAMOV AND MR. FROLOV
20th Oct 20227:45 pmEQSEVRAZ plc: EVRAZ SANCTIONED IN NEW ZEALAND
20th Oct 20227:45 pmEQSEVRAZ plc: EVRAZ SANCTIONED IN NEW ZEALAND
14th Oct 20224:35 pmEQSEVRAZ plc: CHANGES IN THE COMPOSITION OF THE BOARD OF DIRECTORS
14th Oct 20224:35 pmEQSEVRAZ plc: CHANGES IN THE COMPOSITION OF THE BOARD OF DIRECTORS
3rd Oct 202212:14 pmEQSEVRAZ plc: CHANGES IN THE COMPOSITION OF THE BOARD OF DIRECTORS
3rd Oct 202212:14 pmEQSEVRAZ plc: CHANGES IN THE COMPOSITION OF THE BOARD OF DIRECTORS
16th Sep 20226:45 pmEQSEVRAZ plc: UPDATE ON PAYMENT OF INTEREST DUE ON EUROBONDS ISSUED BY EVRAZ PLC
16th Sep 20226:45 pmEQSEVRAZ plc: UPDATE ON PAYMENT OF INTEREST DUE ON EUROBONDS ISSUED BY EVRAZ PLC
16th Sep 202210:24 amEQSEVRAZ plc: Changes in the composition of the Board of Directors
16th Sep 202210:24 amEQSEVRAZ plc: Changes in the composition of the Board of Directors
10th Aug 20224:00 pmEQSEVRAZ is launching soliciting of proposals for its North American subsidiaries acquisition
10th Aug 20224:00 pmEQSEVRAZ is launching soliciting of proposals for its North American subsidiaries acquisition
4th Aug 20227:39 amEQSEVRAZ plc: UNAUDITED INTERIM FINANCIAL RESULTS FOR H1 2022U
4th Aug 20227:37 amEQSEVRAZ plc: UNAUDITED INTERIM FINANCIAL RESULTS FOR H1 2022U
2nd Aug 20228:00 amEQSEVRAZ plc: NOTICE OF H1 2022 RESULTS AND CONFERENCE CALL DETAILS
2nd Aug 20228:00 amEQSEVRAZ plc: NOTICE OF H1 2022 RESULTS AND CONFERENCE CALL DETAILS
28th Jul 20222:33 pmEQSEVRAZ plc: Important notice to noteholders
28th Jul 20222:32 pmEQSEVRAZ plc: Important notice to noteholders
25th Jul 20224:22 pmEQSEVRAZ plc: SPECIAL LICENCE FOR EUROBONDS COUPON PAYMENTS REQUESTED
25th Jul 20224:22 pmEQSEVRAZ plc: SPECIAL LICENCE FOR EUROBONDS COUPON PAYMENTS REQUESTED
21st Jul 20226:15 pmEQSEVRAZ plc: Response to press speculations
21st Jul 20226:15 pmEQSEVRAZ plc: Response to press speculations
18th Jul 20228:39 amEQSEVRAZ plc: Termination of the registry and associated services
18th Jul 20228:38 amEQSEVRAZ plc: Termination of the registry and associated services
30th Jun 20221:55 pmEQSEVRAZ plc: Results of the Annual General Meeting
30th Jun 20221:55 pmEQSEVRAZ plc: Results of the Annual General Meeting
28th Jun 20223:45 pmEQSEVRAZ plc publishes its Modern Slavery Act Transparency Statement for 2021
28th Jun 20223:45 pmEQSEVRAZ plc publishes its Modern Slavery Act Transparency Statement for 2021
17th Jun 20226:57 pmEQSEVRAZ plc: EVRAZ HAS RECEIVED A SPECIAL LICENCE FROM OFSI FOR AGM2022
17th Jun 20226:57 pmEQSEVRAZ plc: EVRAZ HAS RECEIVED A SPECIAL LICENCE FROM OFSI FOR AGM2022

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.